tradingkey.logotradingkey.logo
Discount

The NYSE Welcomes vVARDIS as a Publicly Listed Company

PR NewswireNov 14, 2026 5:23 AM
facebooktwitterlinkedin
View all comments(0)

NEW YORK, Nov. 14, 2026 /PRNewswire/ -- vVARDIS (NYSE: VVVV) co-founders Dr. Haley Abivardi and Dr. Goly Abivardi aim to reshape the future of dental care with a drill-free treatment for the world's #1 non-communicable disease: cavities.


The NYSE welcomes vVARDIS as a publicly listed company! vVARDIS co-founders Dr. Haley Abivardi and Dr. Goly Abivardi aim to reshape the future of dental care with a drill-free treatment for the world’s #1 non-communicable disease: cavities.

  • vVARDIS Solves a Problem that Millions Face
    • Tooth decay affects billions of people worldwide, and dental anxiety keeps millions from getting the care they need.
    • vVARDIS is a Swiss dental technology company focused on changing the way early tooth decay is treated.
    • vVARDIS has introduced a new approach that aims to treat decay earlier and more comfortably for patients.
    • Its flagship product, Curodont® Repair Fluoride Plus, uses proprietary peptide technology to help repair early-stage tooth decay by supporting the natural remineralization of enamel --- simply put No drill, No needle, or No filling.
  • Tooth Decay is One of the Most Common Health Issues in the World
    • 2.5 billion people globally live with untreated tooth decay.
    • Nearly 90% of U.S. adults have experienced tooth decay.
    • Nearly 73% of U.S. adults report dental fear.
    • 21% avoid the dentist because of anxiety.
  • The Story that Helped Shape vVARDIS
    • For decades, treating early tooth decay often meant waiting until it worsened or getting a filling. 
    • The founders spent 25 years developing Curodont® Repair Fluoride Plus, a treatment that helps repair early tooth decay before it becomes a cavity.
    • Curodont® gives dentists a way to treat early decay while making the experience easier and less intimidating for patients.
      • The technology has already treated more than 2.5 million teeth
      • Available in more than 20% of U.S. dental practices

Click Here to Learn More about vVARDIS: https://www.youtube.com/watch?v=T1p9hUR5Glk


The NYSE celebrates vVardis (NYSE: VVVV) IPO

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logotradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.